A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Asan Medical Center
Elsan
The Christie NHS Foundation Trust
Carmel Medical Center
Henan Cancer Hospital
Cambridge University Hospitals NHS Foundation Trust
Federation of Italian Cooperative Oncology Groups
Assiut University
University Hospital, Brest
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Qilu Pharmaceutical Co., Ltd.
Guangdong Provincial People's Hospital
Celtic Biotech Ltd
Akdeniz University
Jinling Hospital, China
Taipei Medical University
Guangzhou First People's Hospital
Pamukkale University
Jiangsu Cancer Institute & Hospital
University of Medicine and Pharmacy at Ho Chi Minh City
Entia Ltd
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
CanWell Pharma Inc.
Ruijin Hospital
University Hospital, Strasbourg, France
Istanbul University - Cerrahpasa
Beijing StarMab Biomed Technology Ltd
Washington University School of Medicine
Hospices Civils de Lyon
University Hospital, Linkoeping
Guy's and St Thomas' NHS Foundation Trust
Karolinska University Hospital
University of Oklahoma
University Hospital Augsburg
Entia Ltd
National Jewish Health
Affiliated Hospital of North Sichuan Medical College
Tianjin Chasesun Pharmaceutical Co., LTD
Assiut University
BeBetter Med Inc
Ain Shams University
MaineHealth
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Sichuan Provincial People's Hospital
Imperial College London
Masaryk University
Duke-NUS Graduate Medical School
West China Hospital
Imperial College London
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.